[조사 보고서] 세계의 올리고뉴클레오티드 합성 시장 2023-2027

■ 영문 제목 : Global Oligonucleotide Synthesis Market 2023-2027
	■ 상품코드 : IRTNTR74336-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 6월 ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문후 24시간내) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD2,500 ⇒환산￦3,375,000	견적의뢰/주문/질문
Enterprise License (기업 열람용)	USD4,000 ⇒환산￦5,400,000	견적의뢰/주문/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

세계의 올리고뉴클레오타이드 합성 시장 2023-2027
올리고뉴클레오티드 합성 시장은 2022년부터 2027년까지 28억 7069만 달러로 성장하며, 예측 기간 동안 13.47%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 올리고뉴클레오티드 합성 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 담고 있습니다.
이 보고서는 현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 제약 및 생명공학 분야의 연구 활동의 활성화, 치료 및 진단 도구로서 올리고뉴클레오타이드의 사용 증가, 올리고뉴클레오타이드 합성의 기술 혁신이 시장을 주도하고 있습니다.

Technavio사의 올리고뉴클레오티드 합성 시장은 다음과 같이 세분화되어 있습니다.

용도별
- PCR 프라이머
- 형광 in situ 하이브리드화
- PCR 분석 및 패널
- DNA 마이크로어레이
- 기타

최종 용도별
- 제약 및 생명공학 기업
- 연구 및 학술 기관
- 진단 연구소
- 병원

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 보고서는 향후 몇 년 동안 올리고뉴클레오티드 합성 시장의 성장을 촉진하는 주요 이유 중 하나로 새로운 올리고뉴클레오티드 치료제 연구개발에 대한 관심이 높아지는 것을 꼽고 있습니다. 또한, 연구 비용의 증가와 저비용 고처리량 올리고뉴클레오타이드 합성에 대한 수요 증가는 시장의 큰 수요로 이어질 것으로 예상되고 있습니다.

이 보고서는 올리고뉴클레오타이드 합성 시장을 조사하고 분석합니다.
- 올리고뉴클레오타이드 합성 시장 규모
- 올리고뉴클레오타이드 합성 시장 예측
- 올리고뉴클레오타이드 합성 시장 산업 분석

이 보고서는 올리고뉴클레오티드 합성 시장의 주요 벤더인 Agilent Technologies Inc., Ajinomoto Co. Inc., Alnylam Pharmaceuticals Inc., Bio Synthesis Inc, Biocon Ltd., Biotage AB, Danaher Corp., Eurofins Scientific SE, General Electric Co., Ionis Pharmaceuticals Inc., Kaneka Corp., LGC Science Group Holdings Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, Mettler Toledo International Inc., QIAGEN NV, Sarepta Therapeutics Inc, Synbio Technologies, Thermo Fisher Scientific Inc., 및 Biogen Inc. 등의 기업 정보를 포함하고 있습니다. 또한, 올리고뉴클레오티드 합성 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가올 성장 기회를 모두 활용할 수 있도록 도와줍니다.

이 연구는 업계 주요 참가자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있는 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.

■ 보고서 개요

1. 개요
2. 세계의 올리고뉴클레오타이드 합성 시장 현황
3. 세계의 올리고뉴클레오타이드 합성 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 용도별 시장 분석
7. 최종 용도별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global oligonucleotide synthesis market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global oligonucleotide synthesis market 2017 – 2021 ($ billion)
o 4.2 Applications Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Applications Segment 2017 – 2021 ($ billion)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application – Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 PCR primers – Market size and forecast 2022-2027
o Exhibit 34: Chart on PCR primers – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on PCR primers – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on PCR primers – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on PCR primers – Year-over-year growth 2022-2027 (%)
o 6.4 Fluorescence in situ hybridization – Market size and forecast 2022-2027
o Exhibit 38: Chart on Fluorescence in situ hybridization – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Fluorescence in situ hybridization – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Fluorescence in situ hybridization – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Fluorescence in situ hybridization – Year-over-year growth 2022-2027 (%)
o 6.5 PCR assays and panels – Market size and forecast 2022-2027
o Exhibit 42: Chart on PCR assays and panels – Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on PCR assays and panels – Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on PCR assays and panels – Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on PCR assays and panels – Year-over-year growth 2022-2027 (%)
o 6.6 DNA microarrays – Market size and forecast 2022-2027
o Exhibit 46: Chart on DNA microarrays – Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on DNA microarrays – Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on DNA microarrays – Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on DNA microarrays – Year-over-year growth 2022-2027 (%)
o 6.7 Others – Market size and forecast 2022-2027
o Exhibit 50: Chart on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ billion)
o Exhibit 55: Data Table on Market opportunity by Application ($ billion)
7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 56: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 57: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 58: Chart on Comparison by End-user
o Exhibit 59: Data Table on Comparison by End-user
o 7.3 Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027
o Exhibit 60: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
o 7.4 Research and academic institutes – Market size and forecast 2022-2027
o Exhibit 64: Chart on Research and academic institutes – Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Research and academic institutes – Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Research and academic institutes – Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Research and academic institutes – Year-over-year growth 2022-2027 (%)
o 7.5 Diagnostic laboratories – Market size and forecast 2022-2027
o Exhibit 68: Chart on Diagnostic laboratories – Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Diagnostic laboratories – Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
o 7.6 Hospitals – Market size and forecast 2022-2027
o Exhibit 72: Chart on Hospitals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Hospitals – Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by End-user
o Exhibit 76: Market opportunity by End-user ($ billion)
o Exhibit 77: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 79: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 81: Chart on Geographic comparison
o Exhibit 82: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 83: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 87: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 91: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 95: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 99: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 China – Market size and forecast 2022-2027
o Exhibit 103: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 Canada – Market size and forecast 2022-2027
o Exhibit 111: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 115: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 119: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 121: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 122: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 123: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 124: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 125: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 126: Matrix on vendor position and classification
o 12.3 Agilent Technologies Inc.
o Exhibit 127: Agilent Technologies Inc. – Overview
o Exhibit 128: Agilent Technologies Inc. – Business segments
o Exhibit 129: Agilent Technologies Inc. – Key offerings
o Exhibit 130: Agilent Technologies Inc. – Segment focus
o 12.4 Alnylam Pharmaceuticals Inc.
o Exhibit 131: Alnylam Pharmaceuticals Inc. – Overview
o Exhibit 132: Alnylam Pharmaceuticals Inc. – Product / Service
o Exhibit 133: Alnylam Pharmaceuticals Inc. – Key news
o Exhibit 134: Alnylam Pharmaceuticals Inc. – Key offerings
o 12.5 Biogen Inc.
o Exhibit 135: Biogen Inc. – Overview
o Exhibit 136: Biogen Inc. – Product / Service
o Exhibit 137: Biogen Inc. – Key offerings
o 12.6 Biotage AB
o Exhibit 138: Biotage AB – Overview
o Exhibit 139: Biotage AB – Product / Service
o Exhibit 140: Biotage AB – Key news
o Exhibit 141: Biotage AB – Key offerings
o 12.7 Danaher Corp.
o Exhibit 142: Danaher Corp. – Overview
o Exhibit 143: Danaher Corp. – Business segments
o Exhibit 144: Danaher Corp. – Key news
o Exhibit 145: Danaher Corp. – Key offerings
o Exhibit 146: Danaher Corp. – Segment focus
o 12.8 Eurofins Scientific SE
o Exhibit 147: Eurofins Scientific SE – Overview
o Exhibit 148: Eurofins Scientific SE – Business segments
o Exhibit 149: Eurofins Scientific SE – Key news
o Exhibit 150: Eurofins Scientific SE – Key offerings
o Exhibit 151: Eurofins Scientific SE – Segment focus
o 12.9 Ionis Pharmaceuticals Inc.
o Exhibit 152: Ionis Pharmaceuticals Inc. – Overview
o Exhibit 153: Ionis Pharmaceuticals Inc. – Business segments
o Exhibit 154: Ionis Pharmaceuticals Inc. – Key news
o Exhibit 155: Ionis Pharmaceuticals Inc. – Key offerings
o Exhibit 156: Ionis Pharmaceuticals Inc. – Segment focus
o 12.10 Kaneka Corp.
o Exhibit 157: Kaneka Corp. – Overview
o Exhibit 158: Kaneka Corp. – Business segments
o Exhibit 159: Kaneka Corp. – Key offerings
o Exhibit 160: Kaneka Corp. – Segment focus
o 12.11 LGC Science Group Holdings Ltd.
o Exhibit 161: LGC Science Group Holdings Ltd. – Overview
o Exhibit 162: LGC Science Group Holdings Ltd. – Product / Service
o Exhibit 163: LGC Science Group Holdings Ltd. – Key offerings
o 12.12 Maravai LifeSciences Holdings Inc.
o Exhibit 164: Maravai LifeSciences Holdings Inc. – Overview
o Exhibit 165: Maravai LifeSciences Holdings Inc. – Business segments
o Exhibit 166: Maravai LifeSciences Holdings Inc. – Key offerings
o Exhibit 167: Maravai LifeSciences Holdings Inc. – Segment focus
o 12.13 Merck KGaA
o Exhibit 168: Merck KGaA – Overview
o Exhibit 169: Merck KGaA – Business segments
o Exhibit 170: Merck KGaA – Key news
o Exhibit 171: Merck KGaA – Key offerings
o Exhibit 172: Merck KGaA – Segment focus
o 12.14 Mettler Toledo International Inc.
o Exhibit 173: Mettler Toledo International Inc. – Overview
o Exhibit 174: Mettler Toledo International Inc. – Business segments
o Exhibit 175: Mettler Toledo International Inc. – Key offerings
o Exhibit 176: Mettler Toledo International Inc. – Segment focus
o 12.15 Sarepta Therapeutics Inc
o Exhibit 177: Sarepta Therapeutics Inc – Overview
o Exhibit 178: Sarepta Therapeutics Inc – Product / Service
o Exhibit 179: Sarepta Therapeutics Inc – Key offerings
o 12.16 Synbio Technologies
o Exhibit 180: Synbio Technologies – Overview
o Exhibit 181: Synbio Technologies – Product / Service
o Exhibit 182: Synbio Technologies – Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 183: Thermo Fisher Scientific Inc. – Overview
o Exhibit 184: Thermo Fisher Scientific Inc. – Business segments
o Exhibit 185: Thermo Fisher Scientific Inc. – Key news
o Exhibit 186: Thermo Fisher Scientific Inc. – Key offerings
o Exhibit 187: Thermo Fisher Scientific Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 188: Inclusions checklist
o Exhibit 189: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 190: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 191: Research methodology
o Exhibit 192: Validation techniques employed for market sizing
o Exhibit 193: Information sources
o 13.5 List of abbreviations
o Exhibit 194: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Application
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global oligonucleotide synthesis market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Applications Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Application – Market share 2022-2027 (%)
Exhibits31: Data Table on Application – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on PCR primers – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on PCR primers – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on PCR primers – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on PCR primers – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Fluorescence in situ hybridization – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Fluorescence in situ hybridization – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Fluorescence in situ hybridization – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Fluorescence in situ hybridization – Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on PCR assays and panels – Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on PCR assays and panels – Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on PCR assays and panels – Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on PCR assays and panels – Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on DNA microarrays – Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on DNA microarrays – Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on DNA microarrays – Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on DNA microarrays – Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others – Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ billion)
Exhibits55: Data Table on Market opportunity by Application ($ billion)
Exhibits56: Chart on End-user – Market share 2022-2027 (%)
Exhibits57: Data Table on End-user – Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by End-user
Exhibits59: Data Table on Comparison by End-user
Exhibits60: Chart on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Pharmaceutical and biotechnology companies – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Pharmaceutical and biotechnology companies – Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Research and academic institutes – Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Research and academic institutes – Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Research and academic institutes – Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Research and academic institutes – Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Diagnostic laboratories – Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Diagnostic laboratories – Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Diagnostic laboratories – Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Hospitals – Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Hospitals – Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits76: Market opportunity by End-user ($ billion)
Exhibits77: Data Table on Market opportunity by End-user ($ billion)
Exhibits78: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits79: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits80: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits81: Chart on Geographic comparison
Exhibits82: Data Table on Geographic comparison
Exhibits83: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on Canada – Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits119: Market opportunity By Geographical Landscape ($ billion)
Exhibits120: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits121: Impact of drivers and challenges in 2022 and 2027
Exhibits122: Overview on Criticality of inputs and Factors of differentiation
Exhibits123: Overview on factors of disruption
Exhibits124: Impact of key risks on business
Exhibits125: Vendors covered
Exhibits126: Matrix on vendor position and classification
Exhibits127: Agilent Technologies Inc. – Overview
Exhibits128: Agilent Technologies Inc. – Business segments
Exhibits129: Agilent Technologies Inc. – Key offerings
Exhibits130: Agilent Technologies Inc. – Segment focus
Exhibits131: Alnylam Pharmaceuticals Inc. – Overview
Exhibits132: Alnylam Pharmaceuticals Inc. – Product / Service
Exhibits133: Alnylam Pharmaceuticals Inc. – Key news
Exhibits134: Alnylam Pharmaceuticals Inc. – Key offerings
Exhibits135: Biogen Inc. – Overview
Exhibits136: Biogen Inc. – Product / Service
Exhibits137: Biogen Inc. – Key offerings
Exhibits138: Biotage AB – Overview
Exhibits139: Biotage AB – Product / Service
Exhibits140: Biotage AB – Key news
Exhibits141: Biotage AB – Key offerings
Exhibits142: Danaher Corp. – Overview
Exhibits143: Danaher Corp. – Business segments
Exhibits144: Danaher Corp. – Key news
Exhibits145: Danaher Corp. – Key offerings
Exhibits146: Danaher Corp. – Segment focus
Exhibits147: Eurofins Scientific SE – Overview
Exhibits148: Eurofins Scientific SE – Business segments
Exhibits149: Eurofins Scientific SE – Key news
Exhibits150: Eurofins Scientific SE – Key offerings
Exhibits151: Eurofins Scientific SE – Segment focus
Exhibits152: Ionis Pharmaceuticals Inc. – Overview
Exhibits153: Ionis Pharmaceuticals Inc. – Business segments
Exhibits154: Ionis Pharmaceuticals Inc. – Key news
Exhibits155: Ionis Pharmaceuticals Inc. – Key offerings
Exhibits156: Ionis Pharmaceuticals Inc. – Segment focus
Exhibits157: Kaneka Corp. – Overview
Exhibits158: Kaneka Corp. – Business segments
Exhibits159: Kaneka Corp. – Key offerings
Exhibits160: Kaneka Corp. – Segment focus
Exhibits161: LGC Science Group Holdings Ltd. – Overview
Exhibits162: LGC Science Group Holdings Ltd. – Product / Service
Exhibits163: LGC Science Group Holdings Ltd. – Key offerings
Exhibits164: Maravai LifeSciences Holdings Inc. – Overview
Exhibits165: Maravai LifeSciences Holdings Inc. – Business segments
Exhibits166: Maravai LifeSciences Holdings Inc. – Key offerings
Exhibits167: Maravai LifeSciences Holdings Inc. – Segment focus
Exhibits168: Merck KGaA – Overview
Exhibits169: Merck KGaA – Business segments
Exhibits170: Merck KGaA – Key news
Exhibits171: Merck KGaA – Key offerings
Exhibits172: Merck KGaA – Segment focus
Exhibits173: Mettler Toledo International Inc. – Overview
Exhibits174: Mettler Toledo International Inc. – Business segments
Exhibits175: Mettler Toledo International Inc. – Key offerings
Exhibits176: Mettler Toledo International Inc. – Segment focus
Exhibits177: Sarepta Therapeutics Inc – Overview
Exhibits178: Sarepta Therapeutics Inc – Product / Service
Exhibits179: Sarepta Therapeutics Inc – Key offerings
Exhibits180: Synbio Technologies – Overview
Exhibits181: Synbio Technologies – Product / Service
Exhibits182: Synbio Technologies – Key offerings
Exhibits183: Thermo Fisher Scientific Inc. – Overview
Exhibits184: Thermo Fisher Scientific Inc. – Business segments
Exhibits185: Thermo Fisher Scientific Inc. – Key news
Exhibits186: Thermo Fisher Scientific Inc. – Key offerings
Exhibits187: Thermo Fisher Scientific Inc. – Segment focus
Exhibits188: Inclusions checklist
Exhibits189: Exclusions checklist
Exhibits190: Currency conversion rates for US$
Exhibits191: Research methodology
Exhibits192: Validation techniques employed for market sizing
Exhibits193: Information sources
Exhibits194: List of abbreviations

※본 조사보고서 [세계의 올리고뉴클레오티드 합성 시장 2023-2027] (코드 : IRTNTR74336-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [세계의 올리고뉴클레오티드 합성 시장 2023-2027] 에 대해서 E메일 문의는 여기를 클릭하세요.

*** 아래는 관련 보고서 소개입니다 ***

세계의 의료용 외골격 시장 (2023~2027) : 이동형 외골격, 고정형 외골격
IRTNTR40722-23 / Technavio / 2022년 12월 / Technavio사는 세계의 의료용 외골격 시장 규모가 2022년부터 2027년까지 연평균 36.43% 성장하여, 974.84백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 리포트는 세계의 의료용 외골격 시장에 대해서 조사 및 분석을 실시하여, 개요,...Global Medical Exoskeleton Market 2023-2027Technavio has been monitoring the medical exoskeleton market and it is poised to grow by $974.84 mn during 2023-2027, accelerating at a CAGR of 36.43% during the forecast period. Our report on the medical exoskeleton market provides a holistic analysis, market size and forecast, trends, growth...

세계의 B형 및 C형 간염 진단 시장 (2023~2027) : 면역 진단, NAT
IRTNTR70927-23 / Technavio / 2022년 12월 / Technavio사는 세계의 B형 및 C형 간염 진단 시장 규모가 2022년부터 2027년까지 연평균 6.12% 감소하여 2,055.79백만 달러에 이를것 으로 예측하고 있습니다. 본 조사 보고서는 세계의 B형 및 C형 간염 진단 시장을...Technavio Announces the Publication of its Research Report - Global Hepatitis B and C Diagnostics Market 2023-2027Technavio recognizes the following companies as the key players in the global hepatitis B and C diagnostics market: Abbott Laboratories, Bio Rad Laboratories Inc., bioMerieux SA, DAAN Gene Co. Ltd., DiaSorin SpA, Enzo Biochem...

세계의 조혈모세포 이식 (HSCT) 시장 (2023~2027) : 골수 이식, 말초혈 줄기 세포 이식, 제대혈 이식
IRTNTR41656-23 / Technavio / 2023년 1월 / Technavio사(테크나비오)의 시장 조사 보고서는 세계의 조혈모세포 이식 (HSCT) 시장 규모가 2022년부터 2027년 사이에 2,383.61백만 달러에 이르며, 예측 기간 동안 CAGR 6.5%로 확대될 것으로 전망하고 있습니다. 또한 본 조사 자료는 세계의...Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2023-2027 Technavio has been monitoring the hematopoietic stem cells transplantation (HSCT) market and is forecast to grow by $2383.61 mn during 2022-2027, accelerating at a CAGR of 6.5% during the forecast period. Our report on the hematopoietic stem cells transplantation (HSCT) market provides...

세계의 망막용 약제 시장 (2023~2027) : 병원 약국, 소매 약국, 온라인 약국
IRTNTR70326-23 / Technavio / 2023년 1월 / Technavio사(테크나비오)의 본 조사 보고서는 세계의 망막용 약제 시장 규모가 2023년과 2027년 사이에 7,275.79백만 달러에 이르며, 예측 기간 중 연평균 성장률은 6.27%가 될 것으로 예상하고 있습니다. 본 보고서는 세계의 망막용 약제...Global Retinal Drugs Market 2023-2027Technavio has been monitoring the retinal drugs market and is forecast to grow by $7275.79 mn during 2022-2027, accelerating at a CAGR of 6.27% during the forecast period. Our report on the retinal drugs market provides a holistic analysis, market size and forecast, trends, growth drivers,...

세계의 병원용 침대 시장 (2023~2027) : 수동, 반자동, 자동
IRTNTR43580-23 / Technavio / 2023년 2월 / Technavio사(테크나비오)는 세계의 병원용 침대 시장 규모가 2022년에서 2027년 사이에 2,324.19백만 달러에 달하며, 예측 기간 동안 연평균 10% 성장할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 병원용 침대 시장에 대해 조사...Global Hospital Beds Market 2023-2027Technavio has been monitoring the hospital beds market and is forecast to grow by $2324.19 mn during 2022-2027, accelerating at a CAGR of 10% during the forecast period. Our report on the hospital beds market provides a holistic analysis, market size and forecast, trends, growth drivers,...

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!